glucose, (beta-d)-isomer has been researched along with Hypertension in 92 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (2.17) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (15.22) | 29.6817 |
| 2010's | 55 (59.78) | 24.3611 |
| 2020's | 21 (22.83) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G; Li, S; Li, X; Liao, W; Pang, Y; Wei, Y; Yu, C; Zhou, J | 1 |
| Hao, LY; Hao, XQ; Jia, Y; Li, SH; Li, XH; Liu, Y; Su, M; Tang, Y; Wei, YL; Zhang, HG; Zhou, JZ | 1 |
| Basbaum, AI; Roderick, RE; St Lezin, E; Taylor, BK | 1 |
| Behuliak, M; Hojná, S; Hüttl, M; Kadlecová, M; Kujal, P; Malínská, H; Marková, I; Miklánková, D; Neckář, J; Papoušek, F; Rauchová, H; Vaněčková, I; Vaňourková, Z; Zicha, J | 1 |
| Cheng, L; Fan, Y; Fu, Q; Lin, W; Liu, F; Wu, X; Zhang, X; Zhou, L | 1 |
| Bautista-Pérez, R; Escalante, B; Flores-Estrada, J; Franco, M; Mercado, A; Pérez-Méndez, O; Pérez-Villavicencio, R | 1 |
| Bezan Petric, U; Fukazawa, A; Hu, MC; Ishizawa, R; Kim, HK; Mizuno, M; Smith, SA; Vongpatanasin, W; Wang, Z | 1 |
| Algara-Suarez, P; Amissi, S; Auger, C; Belcastro, E; Bruckert, C; Chaker, AB; Houngue, U; Jesel, L; Matsushita, K; Morel, O; Mroueh, A; Ohlmann, P; Park, SH; Remila, L; Schini-Kerth, VB | 1 |
| Advani, A; Cherney, DZI; Dubrofsky, L; Kugathasan, L | 1 |
| Feng, B; Ma, X; Sun, K; Xu, G; Zhang, N; Zhou, Y | 1 |
| Wang, L; Wu, W | 1 |
| Barzaghi, F; Carletti, R; Castoldi, G; Colzani, M; di Gioia, CRT; Ippolito, S; Perseghin, G; Stella, A; Zerbini, G | 1 |
| Wilcox, CS | 1 |
| Carnagarin, R; Herat, LY; Kiuchi, MG; Magno, AL; Matthews, VB; Schlaich, MP | 1 |
| Ferreira, JP; Fitchett, D; George, JT; Kraus, BJ; Lauer, S; Ofstad, AP; Rossignol, P; Wanner, C; Zannad, F; Zinman, B; Zwiener, I | 1 |
| Brown, AJM; Gandy, S; Houston, JG; Lang, CC; McCrimmon, R; Struthers, AD | 1 |
| Hara, K; Hatano, M; Hayashino, Y; Iida, S; Ikegami, Y; Isshiki, M; Ito, D; Kitazato, H; Noda, M; Saito, D; Sakuma, I; Satoh-Asahara, N; Shimada, A; Shiojima, I; Sumita, T; Takahashi, K | 1 |
| Fang, Z; Li, Y; Qian, L; Wang, Y; Wu, L; Yan, S; Zheng, Y | 1 |
| Alenina, N; Bader, M; Crespo-Garcia, S; Dechend, R; Ebrahim, M; Golic, M; Grune, J; Haase, N; Herse, F; Heuser, A; Kintscher, U; Kräker, K; Luft, FC; Müller, DN; Reichhart, N; Strauß, O | 1 |
| Cui, L; Hao, Z; Li, G; Liu, Y; Sun, Y; Wen, Y | 1 |
| Ahemad, N; Goh, BH; Khan, SU; Looi, D; Palanisamy, UD | 1 |
| Ambery, P; Berwanger, O; Buenconsejo, J; Chopra, V; Esterline, R; Gasparyan, SB; Javaheri, A; Koch, GG; Kosiborod, M; Langkilde, AM; Martinez, F; Mukhtar, O; Oscarsson, J; Sjöström, CD; Verma, S | 1 |
| Hoshide, S; Ishibashi, S; Kanegae, H; Kario, K; Kato, M; Okada, K | 1 |
| Dong, Q; Li, K; Wang, S; Xing, W; Zhang, H; Zhou, X | 1 |
| Fu, S; Li, Y; Qian, Z; Wu, Y; Yang, D; Zhu, L | 1 |
| Droebner, K; Eitner, F; Freyberger, A; Hartmann, E; Hüser, J; Joseph, A; Kolkhof, P; Mathar, I; Pavkovic, M; Sandner, P | 1 |
| Kountz, DS | 1 |
| Chilton, R; Hehnke, U; Johansen, OE; Tikkanen, I; Woerle, HJ | 1 |
| Kajiya, S; Kawasoe, M; Kawasoe, S; Kubozono, T; Maruguchi, Y; Miyata, M; Ohishi, M; Uenomachi, H | 1 |
| Jaffa, FM; Johnson, E; Kalyani, RR; Shubrook, JH; Skolnik, N | 1 |
| Broedl, UC; Heer, M; Heise, T; Heusser, K; Jordan, J; Lund, SS; Macha, S; Mattheus, M; Tank, J; Wanner, C; Woerle, HJ | 1 |
| Bjornstad, P; Cherney, DZI; Lovshin, JA; Lytvyn, Y; Udell, JA | 1 |
| Fushimi, Y; Hirukawa, H; Kaku, K; Kamei, S; Kaneto, H; Kimura, T; Kinoshita, T; Kohara, K; Mune, T; Nakanishi, S; Nishioka, M; Obata, A; Okauchi, S; Sanada, J; Shimoda, M; Tatsumi, F | 1 |
| Ferdinand, KC; Salsali, A; Seman, L | 1 |
| Ohno, Y; Suzuki, H; Takenaka, T | 1 |
| Abassi, Z; Hollander, K; Landa, N; Leor, J; Naftali-Shani, N; Rath, L; Rosenthal, T; Younis, F | 1 |
| Tahara, A; Takasu, T | 1 |
| Arnold, SV; Ferdinand, KC; Goyal, A; Kosiborod, M; Mehta, SN; Peri-Okonny, PA; Seman, L; Sperling, LS; Tang, F | 1 |
| Cain, VA; Hallow, MK; Heerspink, HJL; Inzucchi, SE; Rossing, P; Sartipy, P; Sjöström, CD; Stefansson, BV | 1 |
| Chen, K; Huang, Y; Liu, X; Lv, L; Sui, Y; Zhang, G; Zhang, Y; Zhuang, Y | 1 |
| Kadir, KA; Palanisamy, UD; Phang, SCW | 1 |
| Ferdinand, KC; George, J; Izzo, JL; Lee, J; Meng, L; Salsali, A; Seman, L | 1 |
| Chang, CY; Chen, WY; Chen, YF; Dai, ZK; Jhuang, WJ; Jhuo, SJ; Lee, AS; Lee, HC; Liu, PL; Shiou, YL | 1 |
| Biancalana, E; Bruno, RM; Dardano, A; Ghiadoni, L; Giannini, L; Parolini, F; Rossi, C; Seghieri, M; Solini, A; Taddei, S | 1 |
| Bautista, R; Escalante, B; Reyes-Pardo, H; Rios, A; Sánchez, D; Vargas-Robles, H | 1 |
| Hase, T; Jokura, H; Shimotoyodome, A; Suzuki, A; Yamamoto, M | 1 |
| Farrell, K; Heise, T; Natarajan, J; Plum-Mörschel, L; Polidori, D; Rothenberg, P; Sha, S; Sica, D; Wang, SS | 1 |
| Bartaun, C; Gembardt, F; Hohenstein, B; Hugo, C; Jarzebska, N; Mayoux, E; Todorov, VT | 1 |
| Bakris, G; Davies, M; de Zeeuw, D; Kline, I; Mayer, C; Meininger, G; Perkovic, V; Usiskin, K; Vijapurkar, U; Woo, V; Yamout, H | 1 |
| Do, GM; Kwon, O; Lee, S; Lim, Y; Park, SY; Shin, JH | 1 |
| Broedl, UC; Green, A; Narko, K; Salsali, A; Tikkanen, I; Woerle, HJ; Zeller, C | 1 |
| Fung, A; Gilbert, RE; Januszewicz, A; Kline, I; Meininger, G; Vijapurkar, U; Weir, MR | 1 |
| Heneghan, CJ; Onakpoya, IJ | 1 |
| Bakris, GL; Majewski, C | 1 |
| Alameddine, A; Ayer, A; Bourreau, J; Custaud, MA; Derbre, S; Fajloun, Z; Gauguier, D; Gauquelin-Koch, G; Navasiolava, N; Yuan, M | 1 |
| Johansson, P; Johnsson, E; List, J; Ptaszynska, A; Sjöström, CD | 1 |
| Broedl, UC; Christiansen, AV; Häring, HU; Kim, G; Meinicke, T; Merker, L; Roux, F; Salsali, A; Woerle, HJ | 1 |
| Hasegawa, K; Hieda, K; Katanasaka, Y; Morimoto, T; Sunagawa, Y | 1 |
| Broedl, UC; Cannon, CP; Chilton, R; Crowe, S; Johansen, OE; Tikkanen, I; Woerle, HJ | 1 |
| Bhaswant, M; Brown, L; Fanning, K; Mathai, ML; Netzel, M; Panchal, SK | 1 |
| Cain, VA; Iqbal, N; Mansfield, TA; Parikh, S; Ptaszynska, A; Weber, MA | 1 |
| Alessi, F; Iqbal, N; Mansfield, TA; Parikh, S; Ptaszynska, A; Weber, MA | 1 |
| Chilton, R; Johansen, OE; Tikkanen, I | 1 |
| Fujisawa, Y; Kittikulsuth, W; Kohno, M; Masaki, T; Mori, H; Nakano, D; Nishiyama, A; Ogata, H; Ohmori, K; Rahman, A; Takeshige, Y | 1 |
| Cain, VA; Gause-Nilsson, I; Heerspink, HJ; Johnsson, E; Sjöström, CD | 1 |
| Ionkova, I; Konstantinov, S; Krasteva, I; Simeonova, R; Vitcheva, V; Zdraveva, P | 1 |
| Athyros, VG; Boutari, C; Imprialos, KP; Karagiannis, AI; Stavropoulos, K | 1 |
| Scheen, AJ | 1 |
| Bloch, MJ | 1 |
| Dong, Q; Fu, F; Gao, F; Liang, X; Liu, Z; Wang, J; Wang, S; Xing, W; Yang, Q; Zhang, H; Zhang, W; Zhou, X | 1 |
| Reed, JW | 1 |
| Broedl, UC; Cannon, CP; Johansen, OE; Ley, L; Mancia, G; Tikkanen, I; Woerle, HJ; Zeller, C | 1 |
| Lazaridis, AA; Ruilope, LM; Ruiz-Hurtado, G; Sarafidis, PA | 1 |
| Yang, YM; Yu, GY; Zhang, Q | 1 |
| Chatsudthipong, V; Muanprasat, C | 1 |
| Giddings, JC; Ikemura, M; Sasaki, Y; Yamamoto, J | 1 |
| Chen, Y; Li, D; Li, Y; Weng, X; Yang, Q; Zhou, S; Zhu, X | 1 |
| Chen, Y; Li, D; Li, Y; Weng, X; Yang, Q; Zhu, X; Zou, L | 1 |
| Mangmool, S; Parichatikanond, W; Pinthong, D | 1 |
| Bodhankar, SL; Mali, VR; Mohan, V | 1 |
| Chan, P; Chen, YJ; Chow, MS; Hsieh, MH; Huang, TY; Kao, PF; Liang, TH; Liu, JC; Sue, YM; Tomlinson, B | 1 |
| Abe, A; Iwasaki, Y; Kondo, M; Kondo, Y; Mitsuzumi, H; Ohtsuki, K; Uemura, K | 1 |
| Alves-Do-Prado, W; Batista, MR; Bazotte, RB; Ferri, LA; Gazola, S; Yamada, SS | 1 |
| Hase, T; Jokura, H; Suzuki, A; Yamamoto, M; Yamamoto, N | 1 |
| Hase, T; Suzuki, A; Yamamoto, M | 1 |
| Hou, WC; Lin, SY; Lu, YL; Wang, CC; Wu, WC | 1 |
| Chan, P; Chen, YJ; Cheng, JT; Hsieh, MH; Liu, JC; Tomlinson, B | 1 |
| Ahmad, SI; Ahmed, M; Akhtar, S; Dar, A; Faizi, S; Hasnain, SN; Hussain, SA; Qazi, A; Qazi, MH; Saleem, R; Siddiqui, BS | 1 |
| Chan, P; Chen, YJ; Cheng, JT; Lee, CN; Liu, JC; Wong, KL | 1 |
| Chan, P; Chen, YJ; Hsieh, MH; Hsu, YH; Kao, PF; Lee, CN; Liu, JC | 1 |
| Zhou, YL | 1 |
| Kaibara, M; Marumoto, Y | 1 |
13 review(s) available for glucose, (beta-d)-isomer and Hypertension
| Article | Year |
|---|---|
The anti-hypertensive effects of sodium-glucose cotransporter-2 inhibitors.
Topics: Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucose; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Sodium; Sodium-Glucose Transporter 2 Inhibitors | 2023 |
Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors.
Topics: Benzhydryl Compounds; Blood Glucose; Blood Pressure; Canagliflozin; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Kidney; Sodium-Glucose Transporter 2 Inhibitors; Sodium-Hydrogen Exchangers | 2020 |
An evaluation of empagliflozin and it's applicability to hypertension as a therapeutic option.
Topics: Benzhydryl Compounds; Glucosides; Humans; Hypertension; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
The effects of gastrodin injection on hypertension: A systematic review and meta-analysis.
Topics: Benzyl Alcohols; Blood Pressure; Glucosides; Humans; Hypertension; Injections | 2020 |
The use of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and hypertension: a focus on African-American populations.
Topics: Benzhydryl Compounds; Black or African American; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Female; Glucosides; Heart Failure; Hospitalization; Humans; Hypertension; Male; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic review and meta-analysis of randomised clinical trials.
Topics: Blood Glucose; Blood Pressure; Cardiovascular Diseases; Chi-Square Distribution; Diabetes Mellitus; Dietary Supplements; Diterpenes, Kaurane; Glucosides; Humans; Hypertension; Protective Factors; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sweetening Agents | 2015 |
Pharmacological effect of functional foods with a hypotensive action.
Topics: Acetic Acid; Animals; Antihypertensive Agents; Catechin; Dioxoles; Diterpenes, Kaurane; Docosahexaenoic Acids; Eicosapentaenoic Acid; Functional Food; gamma-Aminobutyric Acid; Garlic; Glucosides; Humans; Hypertension; Lignans; Onions | 2015 |
Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension.
Topics: Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Vascular Resistance; Weight Loss | 2016 |
Reappraisal of the diuretic effect of empagliflozin in the EMPA-REG OUTCOME trial: Comparison with classic diuretics.
Topics: Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diuretics; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Treatment Outcome | 2016 |
Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure.
Topics: Animals; Antihypertensive Agents; Benzhydryl Compounds; Biomarkers; Blood Glucose; Blood Pressure; Canagliflozin; Comorbidity; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Kidney; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2016 |
Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.
Topics: Antihypertensive Agents; Benzhydryl Compounds; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypertension; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Reference Values; Treatment Outcome | 2017 |
Stevioside and related compounds: therapeutic benefits beyond sweetness.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Carcinogens; Diterpenes, Kaurane; Diuretics; Drug Interactions; Glucosides; Humans; Hyperglycemia; Hypertension; Ion Pumps; Sweetening Agents | 2009 |
23 trial(s) available for glucose, (beta-d)-isomer and Hypertension
| Article | Year |
|---|---|
Effect of SGLT-2 inhibitor, empagliflozin, on blood pressure reduction in Chinese elderly hypertension patients with type 2 diabetes and its possible mechanisms.
Topics: Aged; Benzhydryl Compounds; Blood Pressure; China; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Humans; Hypertension; Hypotension; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2022 |
A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial.
Topics: Aged; Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Glucosides; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged | 2020 |
Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration.
Topics: Aged; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Effects and Mechanisms of Dapagliflozin Treatment on Ambulatory Blood Pressure in Diabetic Patients with Hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Benzhydryl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypertension; Male; Middle Aged | 2020 |
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study.
Topics: Atherosclerosis; Benzhydryl Compounds; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cause of Death; Comorbidity; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 2; Disease Progression; Double-Blind Method; Glucosides; Heart Failure; Humans; Hypertension; Kidney Diseases; Mortality; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Respiratory Insufficiency; SARS-CoV-2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2021 |
Safety and efficacy of empagliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post hoc analysis of data from the SACRA study.
Topics: Aged; Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Japan; Treatment Outcome | 2021 |
Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension.
Topics: Adult; Aged; Benzhydryl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glucosides; Heart Rate; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 2017 |
The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus.
Topics: Adult; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucose; Glucosides; Heart Rate; Humans; Hypertension; Hypoglycemic Agents; Male; Metformin; Middle Aged; Muscle, Skeletal; Renal Elimination; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sympathetic Nervous System | 2017 |
Design of a 24-week trial of empagliflozin once daily in hypertensive black/African American patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Benzhydryl Compounds; Black or African American; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; United States | 2018 |
Antihyperglycemic and Blood Pressure Effects of Empagliflozin in Black Patients With Type 2 Diabetes Mellitus and Hypertension.
Topics: Aged; Benzhydryl Compounds; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypertension; Male; Middle Aged | 2019 |
The Effects of Dapagliflozin on Systemic and Renal Vascular Function Display an Epigenetic Signature.
Topics: Adult; Aged; Analysis of Variance; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Epigenesis, Genetic; Female; Glomerular Filtration Rate; Glucosides; Hospitals, University; Humans; Hydrochlorothiazide; Hypertension; Italy; Male; MicroRNAs; Middle Aged; Prognosis; Renal Circulation; Sodium-Glucose Transporter 2 Inhibitors; Statistics, Nonparametric; Treatment Outcome; Up-Regulation | 2019 |
Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fasting; Female; Glucosides; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Kidney; Male; Metformin; Middle Aged; Plasma Volume; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Treatment Outcome; Water-Electrolyte Balance; Weight Loss | 2014 |
Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension.
Topics: Analysis of Variance; Antihypertensive Agents; Benzhydryl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Administration Schedule; Female; Glucosides; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Treatment Outcome; Weight Loss | 2015 |
Empagliflozin as add-on to metformin in people with Type 2 diabetes.
Topics: Aged; Benzhydryl Compounds; Body Mass Index; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Exercise; Female; Glucosides; Humans; Hyperglycemia; Hypertension; Hypoglycemia; Hypoglycemic Agents; Male; Membrane Transport Modulators; Metformin; Middle Aged; Overweight; Sodium-Glucose Transporter 2 Inhibitors | 2015 |
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.
Topics: Aged; Arteriosclerosis; Benzhydryl Compounds; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Glucosides; Heart Rate; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Risk; Vascular Resistance; Vascular Stiffness | 2015 |
Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study.
Topics: Aged; Antihypertensive Agents; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2016 |
Effects of dapagliflozin on blood pressure in hypertensive diabetic patients on renin-angiotensin system blockade.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Blood Pressure Determination; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Heart Rate; Hemorheology; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Renin-Angiotensin System; Systole; Uric Acid | 2016 |
Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Glucosides; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Renin-Angiotensin System | 2016 |
Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication.
Topics: Antihypertensive Agents; Benzhydryl Compounds; Blood Glucose; Blood Pressure Determination; Comorbidity; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Male; Prospective Studies; Reference Values; Severity of Illness Index; Treatment Outcome | 2016 |
[Effects of gastrodin injection on blood pressure and vasoactive substances in treatment of old patients with refractory hypertension: a randomized controlled trial].
Topics: Aged; Aged, 80 and over; Benzyl Alcohols; Blood Pressure; Endothelins; Female; Glucosides; Humans; Hypertension; Infusions, Intravenous; Male; Nitric Oxide; Phytotherapy | 2008 |
Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Antihypertensive Agents; Blood Pressure; Diterpenes; Diterpenes, Kaurane; Double-Blind Method; Female; Glucosides; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Quality of Life | 2003 |
Investigation of the antihypertensive effect of oral crude stevioside in patients with mild essential hypertension.
Topics: Adult; Antihypertensive Agents; Diterpenes, Kaurane; Double-Blind Method; Female; Glucosides; Humans; Hypertension; Male; Middle Aged; Phytotherapy; Prospective Studies; Stevia | 2006 |
A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Diterpenes; Diterpenes, Kaurane; Double-Blind Method; Female; Glucosides; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Quality of Life; Terpenes | 2000 |
56 other study(ies) available for glucose, (beta-d)-isomer and Hypertension
| Article | Year |
|---|---|
Prenatal exposure to zymosan results in hypertension in adult offspring rats.
Topics: Age Factors; Animals; Blood Pressure; Female; Humans; Hypertension; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Zymosan | 2008 |
Prenatal exposure to inflammation induced by zymosan results in activation of intrarenal renin-angiotensin system in adult offspring rats.
Topics: Angiotensin II; Animals; Blood Pressure; Creatinine; Female; Gene Expression; Hypertension; Inflammation; Kidney Function Tests; Kidney Glomerulus; Polymerase Chain Reaction; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; RNA, Messenger; Zymosan | 2010 |
Hypoalgesia and hyperalgesia with inherited hypertension in the rat.
Topics: Animals; Blood Pressure; Edema; Hot Temperature; Hyperalgesia; Hypertension; Inflammation; Male; Neurons; Pain; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Spinal Cord; Zymosan | 2001 |
Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension.
Topics: Adiposity; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Antioxidants; Benzhydryl Compounds; Blood Pressure; Disease Models, Animal; Energy Metabolism; Glucosides; Hypertension; Male; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Weight Loss | 2021 |
Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats.
Topics: Animals; Benzhydryl Compounds; Ceramides; Diabetes Mellitus, Experimental; Glucosides; Humans; Hypertension; Rats; Sphingolipids; Sphingomyelin Phosphodiesterase; Sphingomyelins | 2022 |
Dapagliflozin Attenuates Sympathetic and Pressor Responses to Stress in Young Prehypertensive Spontaneously Hypertensive Rats.
Topics: Animals; Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Glucosides; Hypertension; Muscle Contraction; Rats; Rats, Inbred SHR; Sympathetic Nervous System | 2022 |
Empagliflozin prevents angiotensin II-induced hypertension related micro and macrovascular endothelial cell activation and diastolic dysfunction in rats despite persistent hypertension: Role of endothelial SGLT1 and 2.
Topics: Angiotensin II; Animals; Benzhydryl Compounds; Blood Pressure; Collagen; Endothelial Cells; Fibrosis; Glucosides; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Rats; Rats, Wistar; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Vascular Cell Adhesion Molecule-1 | 2022 |
Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.
Topics: Animals; Aorta; Benzhydryl Compounds; Biomarkers; Blood Pressure; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytokines; Disease Models, Animal; Female; Fibrosis; Glucosides; Heart Failure; Hypertension; Inflammation Mediators; Lipids; Nitric Oxide; Norepinephrine; Sodium-Glucose Transporter 2 Inhibitors; Sus scrofa; Sympathetic Nervous System; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Angiotensin-converting enzyme inhibiting ability of ethanol extracts, steviol glycosides and protein hydrolysates from stevia leaves.
Topics: Animals; Antihypertensive Agents; Diterpenes, Kaurane; Enzyme Inhibitors; Female; Glucosides; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Plant Extracts; Plant Leaves; Plant Proteins; Protein Hydrolysates; Rats; Rats, Inbred SHR; Stevia; Taste | 2019 |
Renal Anti-Fibrotic Effect of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension.
Topics: Angiotensin II; Animals; Benzhydryl Compounds; Fibrosis; Glucosides; Hypertension; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial.
Topics: Aged; Antihypertensive Agents; Benzhydryl Compounds; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Resistance; Drug Therapy, Combination; Female; Glucosides; Heart Failure; Hospitalization; Humans; Hypertension; Male; Middle Aged; Mortality; Sodium-Glucose Transporter 2 Inhibitors; Treatment Failure; Treatment Outcome | 2020 |
Effects of empagliflozin and target-organ damage in a novel rodent model of heart failure induced by combined hypertension and diabetes.
Topics: Animals; Benzhydryl Compounds; C-Peptide; Cardiotonic Agents; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucosides; Heart Failure; Humans; Hyperinsulinism; Hypertension; Male; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Metabolites of the ellagitannin, geraniin inhibit human ACE;
Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Carboxypeptidases; Computer Simulation; Coumarins; Ellagic Acid; Glucosides; Humans; Hydrolyzable Tannins; Hypertension; Molecular Docking Simulation; Peptidyl-Dipeptidase A; Polyphenols; Rabbits | 2021 |
Tetrahydroxystilbene glycoside improves endothelial dysfunction and hypertension in obese rats: The role of omentin-1.
Topics: Animals; Cytokines; Endothelium, Vascular; Glucosides; GPI-Linked Proteins; Humans; Hypertension; Lectins; Male; Mice; Mice, Knockout; Rats; Rats, Zucker; Stilbenes | 2021 |
Icarrin prevents cardiomyocyte apoptosis in spontaneously hypertensive rats by inhibiting endoplasmic reticulum stress pathways.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Flavonoids; Glucosides; Heart Ventricles; Hypertension; Myocytes, Cardiac; Protective Agents; Rats; Rats, Inbred SHR; Signal Transduction; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2021 |
Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage.
Topics: Animals; Benzhydryl Compounds; Disease Models, Animal; Drug Combinations; Female; Glucosides; Heart Diseases; Hypertension; Kidney Diseases; Naphthyridines; Rats; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes.
Topics: Adult; Antihypertensive Agents; Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypertension; Male; Middle Aged; Obesity; Plasma Volume; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2017 |
Reducing CV risk in diabetes: An ADA update.
Topics: Antihypertensive Agents; Aspirin; Benzhydryl Compounds; Cardiovascular Diseases; Contraindications; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Chronotherapy; Ezetimibe; Fenofibrate; Glucosides; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Life Style; Liraglutide; Metformin; Niacin; PCSK9 Inhibitors; Platelet Aggregation Inhibitors; Risk Reduction Behavior; Thiazolidinediones | 2017 |
Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension.
Topics: Aged; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Treatment Outcome | 2018 |
Impacts of sodium-glucose co-transporter type 2 inhibitors on central blood pressure.
Topics: Adult; Aged; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glucosides; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Kidney; Male; Middle Aged; Sodium; Sodium-Glucose Transporter 2 | 2018 |
Beneficial Effect of the SGLT2 Inhibitor Empagliflozin on Glucose Homeostasis and Cardiovascular Parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) Rat.
Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Blood Pressure; Diabetes Mellitus; Disease Models, Animal; Glucosides; Homeostasis; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Kidney; Male; Pancreas; Proteinuria; Rats, Inbred SHR; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucosides; Hypertension; Kidney; Losartan; Male; Mice, Inbred C57BL; Nephrectomy; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2018 |
Real-world opportunity of empagliflozin to improve blood pressure control in African American patients with type 2 diabetes: A National Cardiovascular Data Registry "research-to-practice" project from the diabetes collaborative registry.
Topics: Aged; Benzhydryl Compounds; Black or African American; Blood Pressure; Blood Pressure Determination; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypertension; Intersectoral Collaboration; Male; Middle Aged; Multicenter Studies as Topic; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Registries; Translational Research, Biomedical; Treatment Outcome; United States | 2019 |
Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers.
Topics: Aged; Albumins; Albuminuria; Benzhydryl Compounds; Biomarkers; Clinical Trials, Phase III as Topic; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Down-Regulation; Female; Glomerular Filtration Rate; Glucosides; Humans; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors | 2019 |
Paeoniflorin improves pressure overload-induced cardiac remodeling by modulating the MAPK signaling pathway in spontaneously hypertensive rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Gene Regulatory Networks; Glucosides; Hypertension; Male; MAP Kinase Signaling System; Monoterpenes; Paeonia; Rats; Rats, Inbred SHR; Ventricular Remodeling | 2019 |
Effects of geraniin (rambutan rind extract) on blood pressure and metabolic parameters in rats fed high-fat diet.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diet, High-Fat; Glucosides; Glycated Hemoglobin; Humans; Hydrolyzable Tannins; Hypertension; Insulin; Male; Plant Extracts; Rats; Rats, Sprague-Dawley; Sapindaceae | 2019 |
The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats.
Topics: Animals; Atrial Function, Left; Atrial Natriuretic Factor; Benzhydryl Compounds; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Fibrosis; Gene Expression Regulation; Glucosides; Heart Failure; Hemodynamics; Hypertension; Male; Myocardium; Natriuretic Peptide, Brain; Rats, Inbred SHR; Rats, Inbred WKY; Recovery of Function; Sodium-Glucose Transporter 2 Inhibitors; Tumor Necrosis Factor-alpha; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II-dependent kidney damage.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzhydryl Compounds; Blood Pressure; Disease Models, Animal; Glomerular Filtration Rate; Glucose; Glucosides; Hypertension; Losartan; Male; Microvilli; Proteinuria; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Effects of continuous ingestion of hesperidin and glucosyl hesperidin on vascular gene expression in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Dietary Supplements; Endothelium, Vascular; Enzyme Repression; Glucosides; Hesperidin; Hypertension; In Vitro Techniques; Male; NADPH Oxidases; Protein Subunits; Random Allocation; Rats; Rats, Inbred SHR; Solubility; Thromboxane B2; Thromboxane-A Synthase; Vascular Resistance | 2013 |
The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.
Topics: Albuminuria; Animals; Benzhydryl Compounds; Blood Glucose; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Female; Glucosides; Hypertension; Hypertrophy; Hypoglycemic Agents; Kidney; Mice; Mice, Obese; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2014 |
Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy.
Topics: Aged; Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glucosides; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Severity of Illness Index; Thiophenes; Treatment Outcome | 2014 |
Acanthopanax divaricatus var. chiisanensis reduces blood pressure via the endothelial nitric oxide synthase pathway in the spontaneously hypertensive rat model.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Eleutherococcus; Endothelium, Vascular; Furans; Glucosides; Humans; Hypertension; Lignans; Male; Nitric Oxide; Nitric Oxide Synthase; Phytotherapy; Plant Extracts; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Umbilical Veins; Vasodilation | 2014 |
Effect of canagliflozin on blood pressure and adverse events related to osmotic diuresis and reduced intravascular volume in patients with type 2 diabetes mellitus.
Topics: Aged; Blood Pressure; Blood Pressure Determination; Canagliflozin; Diabetes Mellitus, Type 2; Diuresis; Female; Glucosides; Humans; Hypertension; Male; Middle Aged; Sodium-Glucose Transporter 2; Thiophenes | 2014 |
Blood pressure reduction: an added benefit of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes.
Topics: Benzhydryl Compounds; Blood Pressure; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Middle Aged; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2015 |
The cardiovascular effects of salidroside in the Goto-Kakizaki diabetic rat model.
Topics: Animals; Aorta; Blood Pressure; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Diabetes Mellitus, Type 2; Endothelium, Vascular; Glucose Intolerance; Glucosides; Guanylate Cyclase; Heart Rate; Hyperglycemia; Hypertension; Male; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type III; Phenols; Rats; Rats, Inbred WKY; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Vasodilation | 2015 |
Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Blood Pressure; Blood Pressure Determination; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Treatment Outcome | 2015 |
Cyanidin 3-glucoside improves diet-induced metabolic syndrome in rats.
Topics: Animals; Anthocyanins; Cardiovascular System; Diet, High-Fat; Dietary Carbohydrates; Dietary Fats; Dietary Supplements; Fruit and Vegetable Juices; Glucosides; Hypertension; Liver; Male; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Prunus domestica; Rats; Rats, Wistar | 2015 |
A sodium-glucose co-transporter 2 inhibitor empagliflozin prevents abnormality of circadian rhythm of blood pressure in salt-treated obese rats.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Circadian Rhythm; Glucose Tolerance Test; Glucosides; Homeostasis; Hypertension; Hypoglycemic Agents; Insulin Resistance; Obesity; Rats; Rats, Inbred OLETF; Sodium Chloride, Dietary; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
Antidiabetic and antioxidant effects of saponarin from Gypsophila trichotoma on streptozotocin-induced diabetic normotensive and hypertensive rats.
Topics: Animals; Antioxidants; Apigenin; Blood Glucose; Blood Pressure; Caryophyllaceae; Diabetes Mellitus, Experimental; Glucosides; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Hypertension; Hypoglycemic Agents; Liver; Male; Malondialdehyde; Molecular Structure; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Streptozocin | 2016 |
Canagliflozin and Hypertension: Is It the Optimal Choice for All Hypertensive Patients?
Topics: Blood Glucose; Canagliflozin; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Sodium-Glucose Transporter 2 | 2016 |
Blood pressure effects of SGLT2 inhibitors make them an attractive option in diabetic patients with hypertension.
Topics: Antihypertensive Agents; Benzhydryl Compounds; Blood Pressure; Blood Pressure Determination; Canagliflozin; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Metformin; Off-Label Use; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
Tetrahydroxystilbene Glucoside Inhibits Excessive Autophagy and Improves Microvascular Endothelial Dysfunction in Prehypertensive Spontaneously Hypertensive Rats.
Topics: Animals; Autophagy; Depression, Chemical; Endothelial Cells; Endothelium, Vascular; Fallopia multiflora; Glucosides; Humans; Hypertension; In Vitro Techniques; Male; Microvessels; Phytotherapy; Proto-Oncogene Proteins c-akt; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases; Vasodilator Agents | 2016 |
Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Body Weight; Deoxyguanosine; Flavanones; Glucosides; Hesperidin; Hypertension; Intracranial Thrombosis; Male; Nitric Oxide; Oxidative Stress; Rats; Rats, Inbred SHR; Vasodilation | 2012 |
[Effects of Tiangou Jiangya capsule on hypertension and hemodynamics in anaesthetized dogs].
Topics: Animals; Antihypertensive Agents; Benzyl Alcohols; Blood Pressure; Disease Models, Animal; Dogs; Drugs, Chinese Herbal; Female; Flavonoids; Furans; Glucosides; Heart Rate; Hemodynamics; Hypertension; Lignans; Male; Oxygen Consumption; Vascular Resistance | 2011 |
[Effects of Tiangou Jiangya capsule on blood pressure in spontaneous hypertensive rat].
Topics: Animals; Antihypertensive Agents; Benzyl Alcohols; Blood Pressure; Disease Models, Animal; Diuresis; Drugs, Chinese Herbal; Flavonoids; Furans; Glucosides; Heart Rate; Hypertension; Lignans; Male; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Ventricular Function, Left | 2011 |
Blockade of the renin-angiotensin system with delphinidin, cyanin, and quercetin.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anthocyanins; Antihypertensive Agents; Blood Pressure; Glucosides; HEK293 Cells; Humans; Hypertension; Quercetin; Renin; Renin-Angiotensin System; Signal Transduction | 2012 |
Antihypertensive and cardioprotective effects of the Lagenaria siceraria fruit in NG-nitro-L-arginine methyl ester (L-NAME) induced hypertensive rats.
Topics: Animals; Antihypertensive Agents; Antioxidants; Apigenin; Blood Pressure; Cardiotonic Agents; Cholesterol; Chromatography, High Pressure Liquid; Cucurbitaceae; Disease Models, Animal; Flavonoids; Fruit; Glucosides; Hypertension; Inflammation; Luteolin; Male; NG-Nitroarginine Methyl Ester; Plant Extracts; Rats; Rats, Wistar | 2012 |
Glucosyl hesperidin improves serum cholesterol composition and inhibits hypertrophy in vasculature.
Topics: Animals; Aorta, Abdominal; Blood Vessels; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Vessels; Glucosides; Hesperidin; Hypertension; Hypertrophy; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Triglycerides | 2003 |
Glucosyl hesperidin prevents endothelial dysfunction and oxidative stress in spontaneously hypertensive rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Deoxyguanosine; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glucosides; Hesperidin; Hypertension; Male; NADPH Oxidases; Nitrates; Nitric Oxide Synthase Type III; Oxidative Stress; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Vasodilation | 2008 |
Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats.
Topics: Acetylcholine; Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Glucosides; Hesperidin; Hypertension; Injections, Intraperitoneal; Male; NG-Nitroarginine Methyl Ester; Nitroprusside; Organ Culture Techniques; Rats; Rats, Inbred SHR; Rats, Wistar; Time; Vasodilation; Vasodilator Agents | 2008 |
Antioxidant, anti-semicarbazide-sensitive amine oxidase, and anti-hypertensive activities of geraniin isolated from Phyllanthus urinaria.
Topics: Administration, Oral; Amine Oxidase (Copper-Containing); Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Glucosides; Hydrolyzable Tannins; Hypertension; Male; Phyllanthus; Phytotherapy; Random Allocation; Rats; Rats, Inbred SHR | 2008 |
Hypotensive effect of chemical constituents from Aloe barbadensis.
Topics: Aloe; Animals; Anthraquinones; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Emodin; Glucosides; Hypertension; Magnetic Resonance Spectroscopy; Phytotherapy; Plant Leaves; Plant Preparations; Plant Roots; Rats | 2001 |
Inhibitory effect of stevioside on calcium influx to produce antihypertension.
Topics: Animals; Antihypertensive Agents; Aorta; Asteraceae; Calcium; Diterpenes; Diterpenes, Kaurane; Dose-Response Relationship, Drug; Glucosides; Hypertension; In Vitro Techniques; Injections, Intraperitoneal; Muscle, Smooth, Vascular; Phytotherapy; Plant Extracts; Rats; Rats, Inbred SHR; Terpenes; Vasoconstriction | 2001 |
Antihypertensive effect of stevioside in different strains of hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diterpenes; Diterpenes, Kaurane; Glucosides; Hypertension; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY; Terpenes | 2002 |
[Chrysanthemum morifolium in the treatment of hypertension].
Topics: Adult; Aged; Chrysanthemum cinerariifolium; Diuretics; Female; Glucosides; Humans; Hypertension; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Middle Aged; Phytotherapy; Plant Extracts; Plants | 1987 |
[Effect of a traditional herbal medicine, tokishakuyakusan, on the fetal development of the spontaneously hypertensive rat].
Topics: Animals; Benzoates; Bridged-Ring Compounds; Drugs, Chinese Herbal; Embryonic and Fetal Development; Female; Glucosides; Glycosides; Hypertension; Medicine, East Asian Traditional; Monoterpenes; Pregnancy; Pregnancy Complications, Cardiovascular; Rats; Rats, Inbred SHR | 1986 |